|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:Novartis_Group
|
|
gptkbp:acquisition
|
gptkb:Novartis
|
|
gptkbp:ceo
|
gptkb:Daniel_P._Gold
|
|
gptkbp:clinical_trial
|
Phase 2
Phase 2 trials
|
|
gptkbp:collaborations
|
academic institutions
|
|
gptkbp:employees
|
50-100
|
|
gptkbp:focus
|
targeted therapies
|
|
gptkbp:founded
|
gptkb:2007
|
|
gptkbp:founder
|
gptkb:Ron_Cohen
|
|
gptkbp:headquarters
|
gptkb:West_Lafayette,_Indiana
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Endocyte
|
|
gptkbp:investment
|
gptkb:Company
|
|
gptkbp:ipo
|
gptkb:2013
|
|
gptkbp:leadership
|
gptkb:John_D._Mc_Carty
gptkb:Michael_A._Mc_Gowan
gptkb:Robert_A._Mc_Carthy
gptkb:Ron_Cohen
gptkb:David_A._Pritchard
|
|
gptkbp:market
|
gptkb:vaccine
oncology
biopharmaceuticals
|
|
gptkbp:partnership
|
gptkb:Incyte_Corporation
gptkb:Eli_Lilly
gptkb:Merck
gptkb:GSK
gptkb:Genentech
gptkb:temple
gptkb:Biogen_Idec
gptkb:Zymeworks
gptkb:physicist
gptkb:Sanofi
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer
gptkb:Roche
gptkb:Amgen
gptkb:Blueprint_Medicines
gptkb:Sorrento_Therapeutics
gptkb:Vertex_Pharmaceuticals
gptkb:Abb_Vie
gptkb:Celgene
gptkb:Novartis_Pharmaceuticals
gptkb:Takeda
|
|
gptkbp:platform
|
biomarker discovery
personalized medicine
theranostics
|
|
gptkbp:products
|
gptkb:Lynparza
E C116
E C145
E C20
|
|
gptkbp:research_focus
|
gptkb:healthcare_organization
ovarian cancer
oncology
diagnostic imaging
hematologic malignancies
|
|
gptkbp:symbol
|
ECYT
|
|
gptkbp:technology
|
radiolabeled agents
small molecule drug conjugates
radiolabeled antibodies
|
|
gptkbp:traded_on
|
gptkb:NASDAQ
|
|
gptkbp:type
|
gptkb:Company
|
|
gptkbp:website
|
www.endocyte.com
|